Bromfenac 0.75 MG/ML Ophthalmic Solution — RxCUI 1790141
RxNorm drug concept · Semantic clinical drug
RxCUI 1790141
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1790141
Official nameBromfenac 0.75 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbromfenac 0.075 % Ophthalmic Solution; bromfenac 0.75 MG/ML (as bromfenac sodium 0.81 MG/ML) Ophthalmic Solution
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)24 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bromfenac Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Bromfenac eye drops are used specifically around the time of cataract surgery. They help reduce inflammation — the swelling and irritation inside your eye — and ease eye pain durin...
- Tilt your head back, pull down your lower eyelid gently, and place one drop into the affected eye once a day. The most important things to remember: don't let the dropper tip touch...
- How do I use the drops correctly without causing problems?
- No — take your contact lenses out before you put the drops in. The preservative in bromfenac eye drops can be absorbed by soft contact lenses, which isn't good for your eyes or you...
🕸️ Concept Web — How Bromfenac 0.75 MG/ML Ophthalmic Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Bromfenac 0.75 MG/ML Ophthalmic Solution
RxCUI 1790141 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Bromfenac
19737IN
-
Bromfenac
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bromsite
1790142BN
-
Bromsite
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bromfenac Ophthalmic Solution
578017SCDF -
Bromfenac Ophthalmic Product
1163102SCDG -
Bromfenac Ophthalmic Solution [Bromsite]
1790144SBDF -
Bromsite Ophthalmic Product
1790145SBDG -
Ophthalmic Solution
7670DF -
Ophthalmic Product
1151135DFG
-
Bromfenac Ophthalmic Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bromfenac 0.75 MG/ML
1790140SCDC -
Bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]
1790146SBD -
Bromfenac 0.75 MG/ML [Bromsite]
1790143SBDC
-
Bromfenac 0.75 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bromfenac 0.75 MG/ML
SCDC · 1790140 -
Bromfenac Ophthalmic Solution
SCDF · 578017 -
Bromfenac Ophthalmic Product
SCDG · 1163102
Brand-Name Concepts
-
Bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]
SBD · 1790146 -
Bromfenac 0.75 MG/ML [Bromsite]
SBDC · 1790143 -
Bromfenac Ophthalmic Solution [Bromsite]
SBDF · 1790144 -
Bromsite Ophthalmic Product
SBDG · 1790145 -
Bromsite
BN · 1790142
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 1790141 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 49708-0754-41 | 1 POUCH in 1 CARTON (49708-754-41) / 1 BOTTLE, DROPPER in 1... | BROMSITE 0.075% | Sun Pharmaceutical Industries, Inc. | 2016-05-01 |
| 49708-0755-41 | 1 POUCH in 1 CARTON (49708-755-41) / 1 BOTTLE, DROPPER in 1... | bromfenac 0.075% | Sun Pharmaceutical Industries, Inc. | 2024-02-07 |
| 68180-0434-01 | 1 BOTTLE in 1 CARTON (68180-434-01) / 5 mL in 1 BOTTLE | BROMFENAC | Lupin Pharmaceuticals, Inc. | 2024-02-12 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (2) ·
Lupin Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.